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Abstract
Background: Although most symptomatic dengue infections follow an uncomplicated course, complications and
unusual manifestations are increasingly being reported due to rising disease burden. Expanded dengue syndrome
is a new entity added into World Health Organization (WHO) classification system to incorporate this wide
spectrum of unusual manifestations. We report a case of expanded dengue syndrome with subacute thyroiditis and
intracerebral hemorrhage. This is the first case report of thyroiditis in dengue infection.
Case presentation: A 20 years old man presented with fever, myalgias, arthralgias, retro-orbital pain, vomiting and
gum bleeding during a large dengue outbreak in Lahore, Pakistan. On 7th day of illness patient became afebrile, but
he developed severe headaches, unconsciousness followed by altered behavior. On 9th day of illness patient
developed painful neck swelling accompanied by fever, tremors, palpitations, hoarseness of voice and odynophagia.
Examination revealed acutely swollen, tender thyroid gland along with features of hyperthyroidism. Laboratory
evaluation revealed stable hematocrit, thrombocytopenia and leukopenia. Patient had seroconverted for
anti-dengue IgM antibodies on the 10th day of illness. A non-contrast Computed Tomogram (CT) of the brain
showed right frontal lobe hematoma. Thyroid profile showed increased free T3 and T4 and low TSH. Technetium
thyroid scan showed reduced tracer uptake. He was diagnosed as having subacute thyroiditis and treated with oral
prednisolone and propranolol. Follow up CT brain showed resolving hematoma. Patient’s recovery was uneventful.
Conclusion: Subacute thyroiditis may develop during the course of dengue fever and should be included as a
manifestation of expanded dengue syndrome. It should be suspected in patients with dengue fever who develop
painful thyroid swelling and clinical features of hyperthyroidism.
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Background
Infection with dengue virus is asymptomatic in majority
of the cases. Based on 1997 World Health Organization
(WHO) classification, symptomatic dengue infection
may be in the form of dengue fever (DF), dengue
hemorrhagic fever (DHF) and dengue shock syndrome
(DSS) [1]. In 2009 WHO classification system, dengue
fever was divided into dengue with or without warning
signs and severe dengue [2]. However in 2011 revised
WHO guidelines, dengue was divided into dengue fever
(DF), dengue hemorrhagic fever (DHF) without shock or
with shock (DSS) and expanded dengue syndrome [3].
Expanded dengue syndrome is a new entity added to
the classification system to incorporate a wide spectrum
of unusual manifestations of dengue infection affecting
various organ systems including gastrointestinal, hepatic,
neurological [4], pulmonary and renal systems. Dengue
is the most rapidly spreading mosquito borne viral dis-
ease in the world [2] and as larger proportion of popula-
tion is being affected, more unusual manifestations are
being reported. We report a case of expanded dengue
syndrome with subacute thyroiditis and intracerebral
hemorrhage. To the best of our knowledge, this is the
first case report of subacute thyroiditis in a patient with
dengue fever.
Case presentation
A 20 years old man was referred to tertiary care hospital
for evaluation of altered behavior and fever during a
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large epidemic of dengue fever in Punjab in 2011. Patient
had high grade fever for which he took self-prescribed
medicines including acetaminophen and ibuprofen. Fever
was accompanied by myalgias, arthralgias, headache,
retro-orbital pain, rigors, chills, vomiting and gum
bleeding. On 7th day of illness his fever resolved, but he
developed severe headache and within few hours be-
came unconscious. Patient regained consciousness after
two hours but headache, altered behavior and loss of
bladder control persisted. In this condition (ie 8th day of
illness) he was brought to the hospital. These symptoms
improved over the next 36 hours. On second day of
hospitalization patient complained of sore throat and
painful swelling in front of neck accompanied by high
grade fever, dysphagia, hoarseness of voice, palpitations,
tremors and increased frequency of bowel movement.
Two of his other family members also had fever and
were diagnosed as having dengue fever.
Physical examination was remarkable for tachycardia
(pulse 110/min), fever (102.6°F), hoarse low intensity
voice, fine tremors and thyroid swelling. Thyroid was
swollen, warm and tender and patient had painful deglu-
tition. There was no cervical lymphadenopathy. Fundo-
scopy revealed a small hemorrhage over nasal aspect of
right optic disc but no papilloedema. All cranial nerves
were intact and there was no motor or sensory deficit.
His serial complete blood counts showed stable
hematocrit (range 41.2% to 44%), progressively decreas-
ing platelet count (109,000/mm3 on day 4 to 60,000/mm3
on day 8) and leukocyte count (4,200/mm3 on day 4 to
3,100/mm3 on day 7). There was a sudden rise in
leukocyte count from 3,100/mm3 on day 7 to 12,800/mm3
on day 8 and 24,000/mm3 on day 10, coinciding with onset
of thyroid swelling (Figure 1). Platelet count started improv-
ing after day 8 of illness. Serum AST levels were 117 U/L
and 67 U/L at admission and discharge respectively. Serum
ALT levels were 62 U/L and 40 U/L at admission and
discharge respectively. During febrile phase anti-dengue
IgM ang IgG were tested negative on screening test (lateral
flow immunoassay). Anti-dengue IgM by ELISA was nega-
tive on day 3 and became positive on day 10. Anti-dengue
IgM antibodies were measured by indirect IgM ELISA using
commercially available kit (Human GmbH, Wiesbaden,
Germany). The ELISA for indirect IgM antibody detection
uses Dengue specific antigens (DEN-Ag) coated on microti-
ter wells. IgM titre on day 10 was 1.937 (cutoff value 0.524).
Non-contrast Computed Tomography of brain showed a
hyperdense area in right frontal lobe surrounded by a ring
of hypodensity (Figure 2). These findings were consist-
ent with the diagnosis of right frontal lobe hematoma
with surrounding edema. Ultrasonography of neck
revealed diffuse heterogeneity and low intensity vascular
flow in the thyroid area without evidence of abscess
formation. Thyroid function tests showed markedly
high free T3 (270.9 ng/dl; reference range 75-195 ng/dl)
and T4 (724.0 nM/L; reference range 60-140 nM/L), and
low Thyroid Stimulating Hormone (TSH) (0.01 mU/L;
reference range 0.5-5 mU/L). Erythrocyte sedimentation
rate (ESR) by Westergren’s method was 62 mm in 1st
hour. On Technetium scanning of the thyroid, the thy-
roid gland was not visualized due to poor tracer uptake
(0.1%; reference range 1-4%).
Patient had no evidence of plasma leakage in the form
of ascites, pleural effusion or hypoalbuminemia.
Fever was treated with acetaminophen and tepid spon-
ging. Raised intracranial pressure due to intracerebral
hemorrhage was treated with head elevation and intra-
venous mannitol. Thyroiditis was treated initially with
40 mg daily dose of oral prednisolone and pain
improved in two days. Dose was subsequently reduced
to 10 mg daily and was tapered off in two weeks. Oral
propranolol was given for relief of symptoms related to
hyperthyroidism during the first week. Patient was dis-
charged on 8th post-admission day.
Figure 1 Patterns of platelet and white cell counts during the illness. Left panel shows platelet counts during the course of the illness.
There is initial thrombocytopenia followed by thrombocytosis and subsequent normalization of platelet count. Transient thrombocytosis is
probably a response to acute inflammation of thyroid. Right panel shows white cell count. Initially there is progressive leucopenia followed by
leukocytosis at the time of thyroiditis.
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Discussion
A large outbreak of dengue fever hit Pakistan in 2011
and more than a million people suffered from symptom-
atic dengue infection. As a result a large number of cases
with atypical manifestations of the disease were seen
during this epidemic. Patient described in this case re-
port is one example and reinforces the concept of classi-
fying these atypical presentations as separate entity
called expanded dengue syndrome [3].
Our patient had two atypical manifestations of dengue
infection: intracerebral hemorrhage and subacute thyroi-
ditis. Intracranial hemorrhage is a rare but well recog-
nized complication of dengue fever [5,6]. These patients
can present with severe headache, loss of consciousness,
localizing signs or altered behavior depending upon site
and size of bleeding. Our patient had altered behavior
and loss of bladder control that is characteristically seen
in frontal lobe lesions. Intracerebral hemorrhage should
be suspected in patients with dengue fever who develop
headache and/or change in mental status. Hemorrhage
within the tumor of pituitary gland resulting in pituitary
apoplexy has also been reported during dengue infection
[7]. Our patient responded well to supportive therapy
directed at lowering the raised intracranial pressure and
showed rapid improvement over 48 hours without any
residual neurological deficit.
Subacute thyroiditis is characterized by neck pain or
discomfort, a tender diffuse goiter, and a predictable
course of thyroid function evolution. Hyperthyroidism is
typically the presentation followed by euthyroidism,
hypothyroidism, and ultimately restoration of normal
thyroid function. Subacute thyroiditis is presumed to be
caused by a viral infection or a postviral inflammatory
process. The majority of patients have a history of an
upper respiratory infection prior to the onset of thyroidi-
tis (typically two to eight weeks beforehand). Clusters of
cases have been reported in association with Coxsackie-
virus, mumps, measles, adenovirus, and other viral infec-
tions [8]. Approximately one-half of patients have
symptoms and signs of hyperthyroidism [9]. There are
no trials assessing optimal treatment of subacute thyroi-
ditis. Patients are treated with acetylsalicylic acid (as-
pirin), a non-steroidal anti-inflammatory drug (e.g.
Ibuprofen) or prednisolone [10]. Therapy for hyperthy-
roidism is often not needed as symptoms, if present, are
mild and short-lived. Those few patients who have
bothersome symptoms of hyperthyroidism, may benefit
from treatment with a beta blocker.
Subacute thyroiditis has not previously been reported
in association with dengue virus infection. Due to high
bleeding risk associated with use of aspirin or an NSAID
in the setting of thrombocytopenia and frontal lobe
hematoma, we preferred the use of oral prednisolone to
treat the acute inflammation in our patient.
Conclusion
Subacute thyroiditis may develop during the course of
dengue fever and should be included as a manifestation
of expanded dengue syndrome. It should be suspected in
patients with dengue fever who develop painful thyroid
swelling and clinical features of hyperthyroidism.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and all accompanying
images. A copy of the written consent is available for
review by the Series Editor of this journal.
Figure 2 Non-Contrast Computed Tomogram of Brain. A.) CT brain obtained at day 8 of the illness showing a right frontal lobe hematoma
seen as a hyperdense lesion surrounded by a thin rim of hypodense area of edema. There is no midline shift. B.). Follow up CT brain obtained on
14th day of illness shows resolving hematoma. Size of hematoma has decreased, however surrounding cerebral edema has increased.
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